ArticleInternational journal of medical sciences2022

Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer.

Shi-Lei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.